With over 25 years in the Data & AI industry, Rich leads our Data & AI Strategy team which helps customers to understand the opportunity that AI presents, informing investment decisions. Initially trained as a data scientist, Rich founded & built one of the most recognized data science consultancies in the UK. In the last 5 years, Rich has focused on using his experience to advise customers on the role that AI will likely play in their future success – writing data & AI strategies & advising leadership teams at some of the most recognized organisations in the world. Rich is a regular keynote speaker, and has been recognised as one of the DataIQ “100 most influential people in data” 4 times.
Dr. Xiong (Sean) Liu is a leader in data science and AI at Novartis. He was a principal data scientist and NLP lead at Lilly. He has 10 years of experience in pharma R&D (diabetes, neuroscience, immunology, and oncology) and 20 years of experience in data mining and machine learning. Dr. Liu is an innovator in AI for health. He has led data and AI programs to accelerate drug development, from target discovery to clinical trials and post-marketing research. His work has broad applications across the pharma value chain and impacted several marketed drugs. Prior to Pharma, he has won multiple Small Business Innovation Research (SBIR) awards from US government agencies for his research in data mining. He specializes in technology innovation, partnerships and strategies.
Anurag is a Senior Director of Oncology Data Science & AI Products at AstraZeneca, where he works across a portfolio of US Oncology products to translate brand objectives into data science & AI solutions. Prior to AstraZeneca, Anurag was at Takeda where he was Head of US Oncology Patient Insights and Real World Data Analytics. He has led several DS&AI initiatives for Pharma Commercial & Medical at Takeda, Genentech & Abbvie. Key accomplishments across these experiences include the delivery of patient journey mapping, predictive models for patient outcomes, KOL identification & mapping, practice informing treatment patterns, AI-driven next best orchestration, and clinical trial recruitment acceleration (pipeline and phase 4 studies) through patient level data-based insights. Anurag holds a Doctor of Medicine (MD) with experience in Oncology, in addition to a Masters in Medical Science & Technology and an MBA.